E. Melamed

6.5k total citations · 1 hit paper
117 papers, 5.1k citations indexed

About

E. Melamed is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, E. Melamed has authored 117 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Neurology, 41 papers in Cellular and Molecular Neuroscience and 22 papers in Molecular Biology. Recurrent topics in E. Melamed's work include Parkinson's Disease Mechanisms and Treatments (43 papers), Neurological disorders and treatments (26 papers) and Neuroscience and Neuropharmacology Research (13 papers). E. Melamed is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (43 papers), Neurological disorders and treatments (26 papers) and Neuroscience and Neuropharmacology Research (13 papers). E. Melamed collaborates with scholars based in Israel, United States and Germany. E. Melamed's co-authors include Franz Hefti, R. J. Wurtman, Daniel Offen, Ruth Djaldetti, I. Ziv, S. Lavy, G R Cooper, R. J. Wurtman, Eduardo Tolosa and Olivier Rascol and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Neurology.

In The Last Decade

E. Melamed

117 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Precursor control of neurotransmitter synthesis.

1980 536 citations Franz Hefti, E. Melamed et al. profile →

Peers

Countries citing papers authored by E. Melamed

Since Specialization

Citations

This map shows the geographic impact of E. Melamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Melamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Melamed more than expected).

Fields of papers citing papers by E. Melamed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Melamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Melamed. The network helps show where E. Melamed may publish in the future.

Co-authorship network of co-authors of E. Melamed

This figure shows the co-authorship network connecting the top 25 collaborators of E. Melamed. A scholar is included among the top collaborators of E. Melamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Melamed. E. Melamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for Huntington's disease 2012 ·Experimental Neurology ·Ofer Sadan, Noam Shemesh, Ran Barzilay, (unknown), Tamar Blumenfeld‐Katzir, Yaniv Assaf, Moshe Yeshurun, Ruth Djaldetti, Yoram Cohen, E. Melamed, Daniel Offen	62
2	DJ-1 Protects Against Dopamine Toxicity: Implications for Parkinson's Disease and Aging 2012 ·The Journals of Gerontology Series A ·Nirit Lev, Yael Barhum, (unknown), Diana E. Ickowicz, Haim Cohen, E. Melamed, Daniel Offen	42
3	High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease 2011 ·Journal of Neural Transmission ·Rivka Inzelberg, J. M. Rabey, E. Melamed, Ruth Djaldetti, (unknown), Samih Badarny, Sharon Hassin‐Baer, Ohad Cohen, Henri Trau, J. Aharon‐Peretz, Ron Milo, M. Schwartz, M. Huberman, Leon Gilead, Micha Barchana, (unknown), Cheryl Fitzer‐Attas, Nir Giladi	23
4	Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice 2011 ·Translational Psychiatry ·Ran Barzilay, Tali Ben‐Zur, Ofer Sadan, (unknown), Michal Taler, Nirit Lev, (unknown), (unknown), Irit Gil‐Ad, E. Melamed, Abraham Weizman, Daniel Offen	23
5	[123I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor 2008 ·Journal of Neural Transmission ·Ruth Djaldetti, Ben I. Nageris, Mordechai Lorberboym, T. A. Treves, E. Melamed, Eitan Yaniv	27
6	Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease 2008 ·Cytotherapy ·Yochai Levy, (unknown), Ran Barzilay, (unknown), Shlomo Bulvik, Yael Barhum, Hana Panet, E. Melamed, Daniel Offen	101
7	123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Recurrent Sudden Falls: Are Such Falls a Distinct Entity? 2007 ·Journal of Nuclear Medicine Technology ·Ruth Djaldetti, (unknown), I. Ziv, E. Melamed, Mordechai Lorberboym	2
8	Autotransplantation of Bone Marrow-Derived Stem Cells as a Therapy for Neurodegenerative Diseases 2007 ·Handbook of experimental pharmacology ·(unknown), E. Melamed, Daniel Offen	44
9	Quantitative measurement of pain sensation in patients with Parkinson disease 2004 ·Neurology ·Ruth Djaldetti, Alexander L. Shifrin, Zeev Rogowski, Elliot Sprecher, E. Melamed, David Yarnitsky	231
10	The effect of deprenyl washout in patients with long-standing Parkinson's disease 2002 ·Journal of Neural Transmission ·Ruth Djaldetti, I. Ziv, E. Melamed	6
11	Levodopa – an exotoxin or a therapeutic drug? 2000 ·Journal of Neurology ·E. Melamed, Daniel Offen, Anat Shirvan, I. Ziv	36
12	RADIOLOGICAL MEDICAL DATA PRESERVATION IN THE SOUTHERN URALS 2000 ·Health Physics ·E. Melamed	2
13	The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's Disease 1997 ·APOPTOSIS ·I. Ziv, Daniel Offen, (unknown), Reuven Stein, Hana Panet, Rina Zilkha‐Falb, Anat Shirvan, Ari Barzilai, E. Melamed	18
14	Dopamine-Induced Apoptosis Is Inhibited in PC12 Cells Expressing Bcl-2 1997 ·Cellular and Molecular Neurobiology ·Daniel Offen, I. Ziv, Hana Panet, Lina Wasserman, Reuven Stein, E. Melamed, Ari Barzilai	59
15	Human T‐cell lymphotropic virus type I in Iranian‐born Mashhadi Jews: Genetic and phylogenetic evidence for common source of infection 1995 ·Journal of Medical Virology ·Vivek R. Nerurkar, Ki‐Joon Song, Rebecca R. Melland, R Yanagihara, Anat Achiron, E. Melamed, B. Shohat, Orit Pinhas‐Hamiel	14
16	Spastic paraparesis associated with human T‐lymphotropic virus type I: A clinical, serological, and genomic study in Iranian‐born Mashhadi Jews 1993 ·Annals of Neurology ·Anat Achiron, Orit Pinhas‐Hamiel, (unknown), Ruth Djaldetti, (unknown), I. Ziv, A. Avni, Gad Frankel, E. Melamed, B. Shohat	28
17	Involvement of ventral noradrenergic bundle in corticosterone secretion following neural stimuli 1988 ·Neuropharmacology ·S. Feldman, N. Conforti, E. Melamed	34
18	The site of dopamine formation in rat striatum after L-dopa administration. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Franz Hefti, E. Melamed, R. J. Wurtman	150
19	Localization of beta receptors in the anterior segment of the rat eye by a fluorescent analogue of propranolol. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Moshe Lahav, E. Melamed, (unknown), Daphné Atlas	10
20	beta-Adrenergic receptors in rat kidney: direct localization by a fluorescent beta-blocker. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Daphné Atlas, E. Melamed, Moshe Lahav	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact